-
2025-523130-11-00
1
Hematological malignancies
-
2025-523157-34-00
5
Rett syndrome
-
2025-523259-72-00
5
Hidradenitis Suppurativa (HS)
-
2025-523389-26-00
5
Relapsed/refractory primary central nervous system lymphoma
-
2025-523555-66-00
5
Myelofibrosis
-
2025-523575-36-00
4
Locally advanced head and neck squamous cell carcinoma (LA-HNSCC)
-
2025-523674-16-00
5
Metabolic Dysfunction-Associated Steatohepatitis (MASH)
-
2025-523675-39-00
5
Metabolic Dysfunction-Associated Steatohepatitis (MASH)
-
2025-523735-19-00
5
Metastatic Microsatellite Stable Colorectal Cancer
-
2025-523869-22-00
5
advanced or metastatic extrapulmonary neuroendocrine carcinoma
-
2025-524765-24-00
5
Rabies infection/prophylaxis
-
2025-524855-30-00
5
Cutaneous Manifestations of Lupus Erythematosus With or Without System
-
2025-524995-53-00
6
Women with endometriosis undergoing IVF/ICSI
-
2025-525009-18-00
5
Pancreatic Ductal Adenocarcinoma
-
2025-521712-19-00
5
2026-07-06
Colorectal Cancer
-
2025-522435-33-00
5
2026-06-17
Hemophilia A
-
2025-524056-63-00
1
2026-06-05
microsatellite instability high/mismatch repair deficient (MSI-H/dMMR)
-
2025-521590-13-00
5
2026-05-28
Moderately to Severely Active Crohn’s Disease
-
2025-523180-38-00
4
2026-05-12
Uncontrolled Moderate to Severe Eosinophilic Asthma
-
2025-524498-17-00
10
2026-05-08
Pretreated Unresectable Locally Advanced or Metastatic human epidermal
-
2024-511593-70-00
5
2026-04-27
Polyarticular-course juvenile idiopathic arthritis
-
2024-519830-22-00
5
2026-04-27
Heart failure due to systemic left ventricular systolic dysfunction
-
2025-522878-36-00
5
2026-04-20
Chronic Spontaneous Urticaria
-
2024-519818-31-01
5
2026-04-10
Endometrial Cancer
Advanced, Recurrent, Metastatic, or Primary Unresec